Carminia Maria Della Corte et al. [73] used a co-culture system of NSCLC to verify the synergistic effect of PD-L1 monoclonal antibody combined with MEK inhibitors in the treatment of NSCLC. Here, CD274 is linked to non-small cell lung carcinoma.